HOT NEWS
Boehringer Ingelheim
Boehringer IngelheimThe Boehringer Ingelheim group is one of the world's 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, it operates globally with 135 affiliates in 47 countries and almost 38,900 employees. Since it was founded in 1885, the family-owned company has been committed to researching, developing, manufacturing and marketing novel products of high therapeutic value for human and veterinary medicine. In 2007, Boehringer Ingelheim posted net sales of 10.9 billion euro while spending one fifth of net sales in its largest business segment Prescription Medicines on research and development. For more information please visit www.boehringer-ingelheim.com.

Boehringer Ingelheim RSS Channel

Title Filter     Display # 
# Article Title Hits
1 Boehringer Ingelheim and the EFSD call for grant applications in diabetes research 3311
2 Boehringer Ingelheim launches beta social game Syrum to promote science and innovation 2971
3 Boehringer Ingelheim and the ETH Zurich announce diabetes and obesity research collaboration 2780
4 Cost effectiveness and clinical efficacy of Pradaxa® (dabigatran etexilate) versus rivaroxaban analysed 3263
5 Boehringer Ingelheim announces changes to Board of Managing Directors 4739
6 Boehringer Ingelheim once again certified as a family-friendly company 3502
7 One million signatures needed to call upon World Health Organisation 3611
8 Boehringer Ingelheim expands capabilities in biopharmaceutical process science 4899
9 Boehringer Ingelheim launches 'Lean-to-Clinic' program for fast drug product supply 4963
10 Boehringer Ingelheim gains approval of extended 4.5 hour time-window for Actilyse® 9704
11 Boehringer Ingelheim and AVEO Pharmaceuticals announce manufacturing agreement for ficlatuzumab 5961
12 Boehringer Ingelheim implements additional guidance supporting appropriate use of Pradaxa® (dabigatran etexilate) in Europe 4649
13 Boehringer Ingelheim and Gilead sign license agreement for novel HIV non-catalytic integrase inhibitors 4465
14 European Respiratory Society (ERS) Awards Annual COPD Research Prize 5036
15 Boehringer Ingelheim and EFSD collaborate to support diabetes research in Europe 5229
16 Boehringer Ingelheim wins Frost & Sullivan Award for Biopharmaceutical Contract Manufacturing 4619
17 €1 Million Awarded to Winning Projects 4354
18 Trajenta® (linagliptin) receives approval for the treatment of type 2 diabetes in Europe 5220
19 Boehringer Ingelheim licenses ProBioGen's novel GlymaxX® technology 4565
20 Positive first half-year 2011 for Boehringer Ingelheim 3722
 
  • «
  •  Start 
  •  Prev 
  •  1 
  •  2 
  •  3 
  •  Next 
  •  End 
  • »
Page 1 of 3